Ads
related to: pharmaceuticals
Search results
FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea
Pharmaceutical Technology via Yahoo Finance· 12 hours agoThe US Food and Drug Administration (FDA) has approved Teva Pharmaceuticals’ AUSTEDO XR...
Cns Pharmaceuticals Inc [CNSP] Shares Fall Approximately
Knox Daily· 15 hours agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cns Pharmaceuticals Inc shares valued at $50,000 were purchased by Climaco ...
Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO...
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights Xenon Pharmaceuticals to hold its Annual General Meeting on 4th of June Total pay for...
FDA approves higher dose of Catalyst's LEMS drug By Investing.com
Investing.com· 4 hours agoCatalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a commercial-stage biopharmaceutical company,...
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
WROC Rochester· 1 day agoFusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced ...
Hedge Funds are Loading Up on This NVIDIA Corp (NVDA) Partner Stock
Insider Monkey via Yahoo Finance· 13 hours agoWe recently published a list of 7 lesser-known, under-the-radar AI stocks hedge funds are piling...
Review: Father and son go cross-country in 'Ezra,' an autism-themed road movie made with sincerity
Los Angeles Times· 3 hours agoDirector Tony Goldwyn opens his family dramedy “Ezra” in the warm, collegial comfort of a comedy...
Recursion Pharmaceuticals Inc [RXRX] Shares Fall
Knox Daily· 15 hours agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Recursion Pharmaceuticals Inc shares valued at ...
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to...
Tri-County Times· 2 days ago(PRNewsfoto/Sagent Pharmaceuticals, Inc.) (PRNewsfoto/Sagent Pharmaceuticals, Inc.)
Coherus Biosciences retains Buy rating on strong launch progress By Investing.com
Investing.com· 3 hours agoOn Thursday, Coherus Biosciences (NASDAQ:CHRS) maintained its Buy rating from TD (TSX:TD) Cowen,...
